YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
DEFECTIVE DRUGS
Parker Waichman Alonso LLP is a leader in a defective drug litigation. We are currently evaluating cases involving the prescription drugs listed below. Please click on a specific drug or fill out the form at the right for a free case evaluation by a qualified attorney.
Defective Drugs
Defective Drugs NewsRSS Feed
Tysabri PML Risk Increases With Use, FDA Says
Feb 8, 2010 | Parker Waichman Alonso LLP
Tysabri, a popular treatment for relapsing multiple sclerosis (MS), is more likely to cause a serious brain infection called progressive multifocal...
HIV Drug Has Liver Risks, FDA Warns
Feb 2, 2010 | Parker Waichman Alonso LLP
The U.S. Food and Drug Administration (FDA) just issued a safety announcement alerting healthcare professionals and patients about a rare, but...
Childhood Vaccine Linked to Increase in Lung Infection
Feb 2, 2010 | Parker Waichman Alonso LLP
A serious lung infection called pneumococcal empyema has been on the rise in children since the PCV7 vaccination was introduced in 2000, according to...
Immune Deficient Infants Face Risk from Rotavirus Vaccine
Jan 28, 2010 | Parker Waichman Alonso LLP
Infants should be screened for severe combined immunodeficiency prior to receiving the rotavirus vaccine, according to a study published in the New...
Botox Lawsuit Claims 7-Year-Old Died From Treatments
Jan 28, 2010
A woman in California has sued Allergan, the maker of Botox, alleging that the drug caused the death of her 7-year-old daughter in 2007....
Have Gallbladder Disease? Yaz Could be to Blame.
Jan 27, 2010 | Parker Waichman Alonso LLP
Gallbladder disease is one of the side effects being attributed to the Yaz birth control pill. Scores of women from around the country have filed...
Lawsuit Alleges Use of Poligrip Proved Deadly
Jan 26, 2010 | Parker Waichman Alonso LLP
Poligrip denture cream has been blamed for the death of Miami man. His wife and daughter have filed suit against GlaxoSmithKline, claiming that...
Biogen Idec Restarts Tysabri Updates
Jan 25, 2010 | Parker Waichman Alonso LLP
The maker of Tysabri will once again provide monthly updates regarding new cases of progressive multifocal leukoencephalopathy, or PML, an often...
FDA Warning Letter Issued over Visipaque Web Site
Jan 25, 2010 | Parker Waichman Alonso LLP
GE Healhcare is in trouble with the U.S. Food & Drug Administration (FDA) over a Web site for its imaging drug, Visipaque. The agency...
Merida Faces European Ban
Jan 22, 2010 | Parker Waichman Alonso LLP
The same day U.S. health regulators warned that Meridia (sibutramine) shouldn’t be given to patients with a history of heart problems, their...
Savella Not Safe or Effective, Should be Banned, Group Says
Jan 22, 2010 | Parker Waichman Alonso LLP
The benefits of the fibromyalgia drug Savella do not outweigh its risks, according to the consumer advocacy group, Public Citizen. The group has...
Meridia Label Changes Announced
Jan 21, 2010 | Parker Waichman Alonso LLP
The U.S. Food & Drug Administration (FDA) today informed healthcare professionals that it had requested and Abbot Laboratories has agreed to add...
Defective Drugs
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS

